Attovia Therapeutics Inc.

08/13/2026 | Press release | Distributed by Public on 08/13/2026 19:53

Statement of Changes in Beneficial Ownership (Form 4)

FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
WALSH COLIN
2. Issuer Name and Ticker or Trading Symbol
Attovia Therapeutics, Inc. [ATTO]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
C/O GOLDMAN SACHS GROUP INC., 2OO WEST STREET
3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026
(Street)
NEW YORK, NY 10282
4. If Amendment, Date Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/05/2026 P 85,000 A $21 85,000 I See Footnotes(1)(2)(3)
Common Stock 08/05/2026 S 988 D $22.03 84,012 I See Footnotes(1)(2)(3)
Common Stock 08/05/2026 S 447 D $21.87 83,565 I See Footnotes(1)(2)(3)
Common Stock 08/05/2026 S 1,332 D $22.03 82,233 I See Footnotes(1)(2)(3)
Common Stock 08/05/2026 S 200 D $22.05 82,033 I See Footnotes(1)(2)(3)
Common Stock 08/05/2026 S 1,556 D $22.06 80,477 I See Footnotes(1)(2)(3)
Common Stock 08/05/2026 S 3,402 D $22.02 77,075 I See Footnotes(1)(2)(3)
Common Stock 08/05/2026 S 200 D $22.1 76,875 I See Footnotes(1)(2)(3)
Common Stock 08/05/2026 S 480 D $21.55 76,395 I See Footnotes(1)(2)(3)
Common Stock 08/05/2026 S 100 D $22.11 76,295 I See Footnotes(1)(2)(3)
Common Stock 08/05/2026 S 753 D $21.97 75,542 I See Footnotes(1)(2)(3)
Common Stock 08/05/2026 S 672 D $22.02 74,870 I See Footnotes(1)(2)(3)
Common Stock 08/05/2026 S 6,970 D $22.03 67,900 I See Footnotes(1)(2)(3)
Common Stock 08/05/2026 S 400 D $22.02 67,500 I See Footnotes(1)(2)(3)
Common Stock 08/05/2026 S 1,180 D $21.84 66,320 I See Footnotes(1)(2)(3)
Common Stock 08/05/2026 S 1,040 D $22.05 65,280 I See Footnotes(1)(2)(3)
Common Stock 08/05/2026 S 300 D $20.84 64,980 I See Footnotes(1)(2)(3)
Common Stock 08/05/2026 S 443 D $21.78 64,537 I See Footnotes(1)(2)(3)
Common Stock 08/05/2026 S 200 D $22.05 64,337 I See Footnotes(1)(2)(3)
Common Stock 08/05/2026 S 700 D $22.07 63,637 I See Footnotes(1)(2)(3)
Common Stock 08/05/2026 S 1,163 D $22.19 62,474 I See Footnotes(1)(2)(3)
Common Stock 08/05/2026 S 100 D $21.99 62,374 I See Footnotes(1)(2)(3)
Common Stock 08/05/2026 S 6,763 D $21.61 55,611 I See Footnotes(1)(2)(3)
Common Stock 08/05/2026 S 76,418 D $21.04 0 I See Footnotes(1)(2)(3)
Common Stock 08/06/2026 C 1,957,134(4)(5) A $ 0 2,042,134(4) I See Footnotes(1)(6)(7)(8)
Common Stock 08/06/2026 C 478,498(4)(5) A $ 0 2,520,632(4) I See Footnotes(1)(6)(7)(8)
Common Stock 08/06/2026 P 500,000 A $17 3,020,632(4) I See Footnotes(1)(2)
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series B Preferred Stock (4) 08/06/2026 C 18,181,830(5) (5) (5) Common Stock 1,957,134(4)(5) $ 0 0 I See Footnote(1)(6)(7)(8)
Series C Preferred Stock (4) 08/06/2026 C 4,445,275(5) (5) (5) Common Stock 478,498(4)(5) $ 0 0 I See Footnote(1)(6)(7)(8)

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
WALSH COLIN
C/O GOLDMAN SACHS GROUP INC.
2OO WEST STREET
NEW YORK, NY 10282
X

Signatures

/s/ Crystal Orgill, Attorney-in-fact 08/13/2026
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest therein, if any, and this report shall not be deemed an admission that any such Reporting Person is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Exchange Act, or for any other purpose.
(2) These transactions in the common stock of the Issuer were effected by Goldman Sachs & Co. LLC ("GS&Co") acting as a market maker in the ordinary course of business. Without conceding market making trades in the ordinary course of business can result in liability under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that they were subject to Section 16(b) will be remitted to the Issuer.
(3) GS&Co's transactions in the Issuer's common stock on August 5, 2026 consisted of purchases of a total of 85,000 shares and sales of a total of 105,807 shares.
(4) The previous report on Form 3 reflected an administrative error with respect to the number of shares of common stock issuable upon conversion of the Preferred Stock, which is corrected in this Form 4.
(5) Each share of Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted into shares of the Issuer's common stock on a 9.29-for-1 basis upon the closing of the Issuer's initial public offering (the "IPO") on August 6, 2026 without payment of consideration. The Preferred Stock has no expiration date.
(6) The Reporting Person is a managing director of GS&Co, a subsidiary of The Goldman Sachs Group Inc. ("GS Group"). GS Group is the direct owner of GS&Co and an indirect owner of Goldman Sachs Asset Management, L.P. ("GSAM LP"). GS&Co is the manager of Broad Street Principal Investments L.L.C. ("BSPI") which directly holds 96,190 shares of common stock purchased in the IPO and 468,565 shares of common stock converted from 3,497,806 shares of Series B Preferred Stock and 855,179 shares of Series C Preferred Stock of the Issuer. GSAM LP is the investment manager of WSLS Offshore Investments, SLP ("WSLS Offshore") which directly holds 131,283 shares of common stock purchased in the IPO and 639,518 shares of common stock converted from 4,773,948 shares of Series B Preferred Stock and 1,167,182 shares of Series C Preferred Stock of the Issuer,... (continued in footnote 7)
(7) (continued from footnote 6)... West Street Life Sciences I, L.P. ("WSLS I") which directly holds 137,708 shares of common stock purchased in the IPO and 670,812 shares of common stock converted from 5,007,564 shares of Series B Preferred Stock and 1,224,299 shares of Series C Preferred Stock of the Issuer, WSLS Emp Offshore Investments, L.P. ("WSLS Emp Offshore") which directly holds 36,927 shares of common stock purchased in the IPO and 179,879 shares of common stock converted from 1,342,794 shares of Series B Preferred Stock and 328,300 shares of Series C Preferred Stock of the Issuer, and WSLS Emp Onshore Investments, L.P. ("WSLS Emp Onshore") which directly holds 97,892 shares of common stock purchased in the IPO and 476,858 shares of common stock converted from 3,559,718 shares of Series B Preferred Stock and 870,315 shares of Series C Preferred Stock of the Issuer,... (continued in footnote 8)
(8) (continued from footnote 7)... GS&Co is a direct subsidiary of GS Group and is the manager of BSPI. WSLS Offshore, WSLS I, WSLS Emp Offshore, and WSLS Emp Onshore are investment vehicles managed by GSAM LP, an indirect subsidiary of GS Group.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
Attovia Therapeutics Inc. published this content on August 13, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on August 14, 2026 at 01:53 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]